Abbott says FDA approved heart valve medical device
Oct 25 (Reuters) - Abbott Laboratories said on Friday that the U.S. Food and Drug Administration approved its MitraClip medical device, used to stop heart valve leakage.
A slim majority of advisers to the FDA had recommended approval of the implantable heart device, as some had questioned whether it would be effective for its intended use.
The device was already approved for use in Europe and sells in 30 countries. It is used to treat mitral regurgitation, a condition in which the mitral valve of the heart does not close properly, causing blood leakage that can lead to stroke, heart attack or even death. It is designed for people who are considered to be at high risk for open-heart surgery.
It has estimated the disorder affects about one in 10 people aged 75 and older.
- Air strike kills 15 civilians in Yemen by mistake: officials
- Pope attacks mega-salaries and wealth gap in peace message
- Probation for drunk Texas teen driver who killed four sparks backlash
- North Korea says Jang Song Thaek, uncle of leader Kim Jong Un, executed
- Atheists face death in 13 countries, global discrimination: study